Arkade Q2 FY27: PAT down 46% YoY to ₹24.8 Cr (consolidated) as billing slows, margins hold
Arkade Developers' consolidated PAT fell 45.8% YoY to ₹24.81 Cr in Q2 FY27 (quarter ended September 30, 2026), on a 45.1% YoY drop in revenue from operations to ₹144.65 Cr from ₹263.65 Cr a year ago — even as PAT rose 30.0% sequentially from Q1's ₹19.08 Cr. No Q2-specific consensus estimate could be located; the only external reference point, Univest's FY27 outlook modelling ~15-20% full-year PAT growth, is running well behind the actual trajectory — H1 FY27 consolidated PAT attributable to owners of ₹43.88 Cr is down roughly 41% YoY from ₹74.56 Cr in H1 FY26, so the stock is tracking a miss against that annual run-rate.
Operating margin (EBITDA/revenue) of 23.87% was broadly steady YoY (23.98% in Q2 FY26) — consistent with the company's own board-meeting characterisation that margins held even as billing slowed — but management's Q1 FY27 concall had guided FY27 EBITDA margins to 25-26% (already lowered from 27-28%). Both this quarter's 23.87% and the H1 FY27 average of roughly 21.4% run below that band, so margin guidance is tracking a miss through the first half. Net margin of 16.90% was marginally below the year-ago 17.30% and sharply up from Q1's 12.83%, though the QoQ jump in both OPM and NPM reflects a low base in Q1's billing rather than a structural improvement. No exceptional items hit either this quarter or the year-ago quarter, so the YoY decline is fully organic — driven by slower revenue recognition, as the company's own filing headline put it.
Standalone and consolidated numbers are near-identical this quarter (standalone PAT ₹24.77 Cr vs consolidated ₹24.81 Cr), so there is no basis divergence to flag. The board also approved incorporating a new wholly-owned subsidiary and a Company Secretary transition (Sheetal Solani proceeding on maternity leave from November 30, 2026, with Maria S John as interim CS from December 1), both administrative and unrelated to the quarter's numbers; no earnings press release accompanied this filing, so management's own framing of the print is unavailable beyond the board-meeting headline already reflected above.
The swing factor for H2 FY27 is execution against management's own FY27 targets — ₹1,000 Cr of pre-sales (₹500 Cr from new launches, ₹500 Cr from ongoing inventory) and ₹3,000 Cr of planned Q3/Q4 launches — none of which this P&L filing can confirm, since it reports revenue recognition rather than booking value.